Mérieux Equity Partners

All figures cover the European funds tracked here since 1 January 2025, whether closed or still raising, and are compiled from public sources.

Tracked funds

1

Reported volume

€335m

Latest public closing

9 Jul 2026

Reported volume sums the public fund amounts tracked here, not the manager's firm-wide assets under management, so it may differ from totals on the manager's website.

European investment firm focused on healthcare, investing through venture capital and buyout platforms.

Focus: Healthcare across company stages: diagnostics, therapeutics, medtech and pharma services

9 July 2026: Mérieux Participations 5 held a first close at €335m against a €600m target (company press release).